Spotlight On Non-Small Cell Lung Cancer
Up to 85 percent of all lung cancer cases are characterized as non-small cell lung cancer, underscoring the importance of keeping up to date on the latest diagnostic and treatment advances. That’s why this Spotlight on Non-Small Cell Lung Cancer brings together leading oncologists and other allied healthcare professionals to discuss key research updates and other novel insights.
1-15 of 38
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Project Oncology®Integrating Molecular Testing into NSCLC Care
Geoffrey Oxnard, MD
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®Smarter Screening for Non-Small Cell Lung Cancer
Jobelle Baldonado, MD
A New Era of Hope in Non-Small Cell Lung Cancer Care
Project Oncology®A New Era of Hope in Non-Small Cell Lung Cancer Care
Geoffrey Oxnard, MD
Improving Adherence and Toxicity Monitoring in NSCLC Care
Project Oncology®Improving Adherence and Toxicity Monitoring in NSCLC Care
Raghava Reddy Induru, MD
The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Project Oncology®The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Raghava Reddy Induru, MD
- advertisement
Antibody-Drug Conjugates for NSCLC: How They Work and Who’s a Candidate
Project Oncology®Antibody-Drug Conjugates for NSCLC: How They Work and Who’s a Candidate
Laura Alder, MD
Key Questions Shaping Antibody-Drug Conjugate Use in NSCLC
Project Oncology®Key Questions Shaping Antibody-Drug Conjugate Use in NSCLC
Laura Alder, MD
Managing Antibody-Drug Conjugate Toxicities in NSCLC Care
Project Oncology®Managing Antibody-Drug Conjugate Toxicities in NSCLC Care
Laura Alder, MD
The Importance of Multidisciplinary Coordination in NSCLC Care
Project Oncology®The Importance of Multidisciplinary Coordination in NSCLC Care
Laura Alder, MD
Emerging Biomarker Research for NSCLC Antibody-Drug Conjugates
Project Oncology®Emerging Biomarker Research for NSCLC Antibody-Drug Conjugates
Christine Bestvina, MD
Innovations Shaping the Future of Antibody-Drug Conjugates in NSCLC
Project Oncology®Innovations Shaping the Future of Antibody-Drug Conjugates in NSCLC
Christine Bestvina, MD
- advertisement
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Project Oncology®Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Raghava Reddy Induru, MD
